Cumberland Long Term Debt Total vs Total Assets Analysis

CPIX Stock  USD 1.06  0.02  1.85%   
Cumberland Pharmaceuticals financial indicator trend analysis is way more than just evaluating Cumberland Pharmaceuticals prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cumberland Pharmaceuticals is a good investment. Please check the relationship between Cumberland Pharmaceuticals Long Term Debt Total and its Total Assets accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cumberland Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
For more information on how to buy Cumberland Stock please use our How to Invest in Cumberland Pharmaceuticals guide.

Long Term Debt Total vs Total Assets

Long Term Debt Total vs Total Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Cumberland Pharmaceuticals Long Term Debt Total account and Total Assets. At this time, the significance of the direction appears to have very week relationship.
The correlation between Cumberland Pharmaceuticals' Long Term Debt Total and Total Assets is 0.27. Overlapping area represents the amount of variation of Long Term Debt Total that can explain the historical movement of Total Assets in the same time period over historical financial statements of Cumberland Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Cumberland Pharmaceuticals' Long Term Debt Total and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Debt Total of Cumberland Pharmaceuticals are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Long Term Debt Total i.e., Cumberland Pharmaceuticals' Long Term Debt Total and Total Assets go up and down completely randomly.

Correlation Coefficient

0.27
Relationship DirectionPositive 
Relationship StrengthVery Weak

Long Term Debt Total

Total Assets

Total assets refers to the total amount of Cumberland Pharmaceuticals assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Cumberland Pharmaceuticals books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.
Most indicators from Cumberland Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cumberland Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cumberland Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
For more information on how to buy Cumberland Stock please use our How to Invest in Cumberland Pharmaceuticals guide.Discontinued Operations is likely to rise to about 2.4 M in 2024, whereas Selling General Administrative is likely to drop slightly above 8.9 M in 2024.
 2021 2022 2023 2024 (projected)
Interest Expense98.0K586.0K667.9K701.3K
Depreciation And Amortization4.6M5.3M5.8M6.1M

Cumberland Pharmaceuticals fundamental ratios Correlations

0.390.520.480.640.090.87-0.230.390.330.50.490.50.490.10.370.540.38-0.090.430.050.750.190.660.180.13
0.390.680.92-0.440.60.380.69-0.590.83-0.390.87-0.530.75-0.650.990.580.550.170.980.53-0.22-0.160.760.770.89
0.520.680.84-0.130.390.490.42-0.240.58-0.240.69-0.240.69-0.450.680.620.310.240.770.350.05-0.120.80.30.54
0.480.920.84-0.340.550.480.67-0.460.86-0.420.93-0.480.82-0.70.920.580.430.330.970.49-0.17-0.050.90.690.81
0.64-0.44-0.13-0.34-0.380.53-0.820.85-0.380.87-0.290.96-0.180.68-0.470.02-0.05-0.3-0.42-0.360.940.3-0.05-0.43-0.61
0.090.60.390.55-0.380.410.63-0.760.72-0.390.54-0.480.54-0.620.53-0.020.160.130.550.99-0.31-0.40.30.790.7
0.870.380.490.480.530.41-0.10.140.50.40.50.380.51-0.090.330.280.44-0.050.40.410.60.110.570.390.22
-0.230.690.420.67-0.820.63-0.1-0.850.74-0.910.64-0.930.4-0.930.690.260.110.560.70.6-0.74-0.360.480.710.88
0.39-0.59-0.24-0.460.85-0.760.14-0.85-0.630.73-0.390.87-0.350.76-0.58-0.03-0.21-0.18-0.54-0.750.740.43-0.13-0.69-0.8
0.330.830.580.86-0.380.720.50.74-0.63-0.460.8-0.530.73-0.840.80.420.440.340.840.7-0.230.00.710.810.86
0.5-0.39-0.24-0.420.87-0.390.4-0.910.73-0.46-0.420.95-0.150.81-0.42-0.060.13-0.65-0.43-0.370.880.35-0.27-0.47-0.63
0.490.870.690.93-0.290.540.50.64-0.390.8-0.42-0.470.75-0.680.870.420.420.370.920.47-0.21-0.110.910.80.77
0.5-0.53-0.24-0.480.96-0.480.38-0.930.87-0.530.95-0.47-0.270.82-0.55-0.06-0.04-0.44-0.53-0.460.920.34-0.25-0.59-0.73
0.490.750.690.82-0.180.540.510.4-0.350.73-0.150.75-0.27-0.460.740.330.40.040.790.46-0.020.10.680.570.55
0.1-0.65-0.45-0.70.68-0.62-0.09-0.930.76-0.840.81-0.680.82-0.46-0.65-0.21-0.25-0.58-0.68-0.610.620.09-0.57-0.73-0.82
0.370.990.680.92-0.470.530.330.69-0.580.8-0.420.87-0.550.74-0.650.610.540.180.980.46-0.25-0.180.760.730.89
0.540.580.620.580.02-0.020.280.26-0.030.42-0.060.42-0.060.33-0.210.610.270.090.61-0.050.28-0.070.640.090.51
0.380.550.310.43-0.050.160.440.11-0.210.440.130.42-0.040.4-0.250.540.27-0.230.50.130.10.110.390.370.38
-0.090.170.240.33-0.30.13-0.050.56-0.180.34-0.650.37-0.440.04-0.580.180.09-0.230.250.13-0.380.030.40.260.29
0.430.980.770.97-0.420.550.40.7-0.540.84-0.430.92-0.530.79-0.680.980.610.50.250.49-0.22-0.130.840.730.87
0.050.530.350.49-0.360.990.410.6-0.750.7-0.370.47-0.460.46-0.610.46-0.050.130.130.49-0.29-0.380.240.750.66
0.75-0.220.05-0.170.94-0.310.6-0.740.74-0.230.88-0.210.92-0.020.62-0.250.280.1-0.38-0.22-0.290.30.05-0.4-0.43
0.19-0.16-0.12-0.050.3-0.40.11-0.360.430.00.35-0.110.340.10.09-0.18-0.070.110.03-0.13-0.380.30.05-0.27-0.38
0.660.760.80.9-0.050.30.570.48-0.130.71-0.270.91-0.250.68-0.570.760.640.390.40.840.240.050.050.540.62
0.180.770.30.69-0.430.790.390.71-0.690.81-0.470.8-0.590.57-0.730.730.090.370.260.730.75-0.4-0.270.540.83
0.130.890.540.81-0.610.70.220.88-0.80.86-0.630.77-0.730.55-0.820.890.510.380.290.870.66-0.43-0.380.620.83
Click cells to compare fundamentals

Cumberland Pharmaceuticals Account Relationship Matchups

Cumberland Pharmaceuticals fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets104.5M96.5M84.5M92.9M81.8M88.1M
Short Long Term Debt Total21.5M17.1M16.1M21.0M18.4M11.9M
Other Current Liab7.7M9.1M8.7M17.6M13.6M7.7M
Total Current Liabilities24.2M25.7M19.3M28.6M28.0M16.8M
Total Stockholder Equity51.1M47.0M42.8M36.3M29.6M58.3M
Property Plant And Equipment Net3.7M2.6M1.5M5.5M7.0M7.4M
Net Debt(6.7M)(7.7M)(11.0M)1.2M106.9K112.2K
Retained Earnings1.2M(2.1M)(5.6M)(11.2M)(17.5M)(16.6M)
Accounts Payable10.0M13.4M9.6M10.8M14.0M14.7M
Cash28.2M24.8M27.0M19.8M18.3M27.3M
Non Current Assets Total54.4M46.5M38.8M47.1M46.1M27.5M
Cash And Short Term Investments28.2M24.8M27.0M19.8M18.3M31.1M
Net Receivables7.9M12.4M6.9M13.2M9.8M7.4M
Common Stock Shares Outstanding15.4M15.2M14.9M14.6M14.3M13.5M
Liabilities And Stockholders Equity104.5M96.5M84.5M92.9M81.8M88.1M
Non Current Liabilities Total29.3M23.9M22.6M28.4M24.5M13.1M
Inventory8.9M10.6M8.4M9.4M4.6M7.3M
Other Current Assets2.8M2.2M6.7M3.1M3.0M2.4M
Other Stockholder Equity2.9M3.1M3.4M(212.3K)(244.2K)(256.4K)
Total Liab53.5M49.6M41.9M57.0M52.5M29.9M
Property Plant And Equipment Gross3.7M2.6M1.5M5.5M9.3M9.7M
Total Current Assets50.2M50.0M45.7M45.9M35.7M60.5M
Intangible Assets30.9M28.1M24.0M30.6M22.6M19.2M
Non Currrent Assets Other18.9M14.9M12.5M10.0M15.5M16.3M
Other Liab8.7M7.9M7.5M7.6M8.7M9.2M
Other Assets18.9M17.8M12.5M10.0M11.6M7.4M
Long Term Debt20M18.5M15M16.2M12.8M9.3M
Common Stock49.9M49.1M48.5M47.5M47.1M44.7M
Property Plant Equipment16.3M12.2M1.5M5.5M6.3M6.6M
Net Tangible Assets19.3M18.0M18.0M4.8M4.3M4.1M
Noncontrolling Interest In Consolidated Entity(198.6K)(274.3K)(37.6K)(117.1K)(105.4K)(110.7K)
Common Stock Total Equity52.4M51.1M49.9M49.1M44.2M46.2M
Retained Earnings Total Equity11.7M4.7M1.2M(2.1M)(1.9M)(1.8M)
Long Term Debt Total9.8M20M18.5M15M17.3M10.8M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Cumberland Stock Analysis

When running Cumberland Pharmaceuticals' price analysis, check to measure Cumberland Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cumberland Pharmaceuticals is operating at the current time. Most of Cumberland Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cumberland Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cumberland Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cumberland Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.